Global Biologics Market Set to Surpass USD 1107.30 Billion by 2031 Amid Rising Demand for Advanced Therapeutics

The market’s growth trajectory reflects the increasing adoption of biologic therapies across oncology, autoimmune diseases, infectious diseases, and rare genetic disorders worldwide.